Matches in Wikidata for { <http://www.wikidata.org/entity/Q93475895> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q93475895 description "clinical trial" @default.
- Q93475895 description "ensayo clínico" @default.
- Q93475895 description "ensayu clínicu" @default.
- Q93475895 description "klinisch onderzoek" @default.
- Q93475895 description "клінічне випробування" @default.
- Q93475895 description "临床试验" @default.
- Q93475895 name "Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer" @default.
- Q93475895 name "Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer" @default.
- Q93475895 type Item @default.
- Q93475895 label "Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer" @default.
- Q93475895 label "Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer" @default.
- Q93475895 prefLabel "Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer" @default.
- Q93475895 prefLabel "Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer" @default.
- Q93475895 P1132 Q93475895-1720434C-8761-4FE3-8CAB-450A5FE1693F @default.
- Q93475895 P1476 Q93475895-58898E42-2828-4D7E-8E3D-13CA94FC440C @default.
- Q93475895 P1813 Q93475895-6525F57E-0A6C-46F5-AB31-E51AE43EF24C @default.
- Q93475895 P2899 Q93475895-F6493238-65AE-4F6E-BD53-FEE13F3330F3 @default.
- Q93475895 P3098 Q93475895-2375CFC6-D13C-49EA-8B7B-4CEA21F7DDD8 @default.
- Q93475895 P31 Q93475895-5102362A-EB08-4D8B-8B4D-8C84651DB196 @default.
- Q93475895 P4135 Q93475895-6C55D050-CAAE-4D25-9F3A-2470A15A8AA1 @default.
- Q93475895 P4844 Q93475895-FE42E796-9DA0-4060-B9C7-91D4ADE5D56D @default.
- Q93475895 P580 Q93475895-9A729D16-80CA-4888-A941-4006F0DB1959 @default.
- Q93475895 P582 Q93475895-AA86B34E-117F-44BD-A8F8-6A4BB5B91D3D @default.
- Q93475895 P6099 Q93475895-90A21E7F-511C-4694-96B1-5A738065E3C5 @default.
- Q93475895 P8005 Q93475895-AC2C2595-8AE8-4A28-940A-849DD8FC1F3F @default.
- Q93475895 P8363 Q93475895-A21882F6-D9EB-4B25-856C-D7996BE298DE @default.
- Q93475895 P1132 "+40" @default.
- Q93475895 P1476 "An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer (Ovarian Cancer)" @default.
- Q93475895 P1813 "ANNIE" @default.
- Q93475895 P2899 "+18" @default.
- Q93475895 P3098 "NCT04376073" @default.
- Q93475895 P31 Q30612 @default.
- Q93475895 P4135 "+70" @default.
- Q93475895 P4844 Q25326660 @default.
- Q93475895 P580 "2020-06-01T00:00:00Z" @default.
- Q93475895 P582 "2021-12-31T00:00:00Z" @default.
- Q93475895 P6099 Q42824440 @default.
- Q93475895 P8005 Q76649708 @default.
- Q93475895 P8363 Q78089383 @default.